From PCOS to PMOS: Understanding the Global Rebrand and What It Means for Perimenopause

Have you ever felt like a name just didn't fully represent something? Maybe it's your own name, the name of your town, or even the name of a dish on a menu. It can feel misleading or difficult to relate to. That's exactly how many of the more than 170 million people worldwide living with Polycystic Ovary Syndrome (PCOS) felt for years.

As of May 2026, the condition was officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) by the Endocrine Society and the Society for Women's Health Research (SWHR). The transition reflects something experts have known for years: the condition was never just about ovarian cysts or fertility. It's a complex endocrine and metabolic disorder that affects multiple systems throughout the body.

This change is significant for women of all ages, including those entering perimenopause and menopause. For years, PCOS was largely associated with irregular periods and fertility challenges, even though those symptoms don't reflect the full picture, especially for women who are no longer in their reproductive years. 

The new name shifts the focus to what the condition has always been: a lifelong endocrine and metabolic disorder that can continue to affect cardiometabolic health well into midlife and beyond.

Why PCOS Is Becoming PMOS

Polycystic ovary syndrome was never actually defined by ovarian cysts. The “cysts” seen on a transvaginal ultrasound are actually immature follicles, not true ovarian cysts. In fact, many women with the condition don't have polycystic-appearing ovaries at all.

Similarly, other women who have ovaries with follicles bubbling around them might not have either of the other diagnostic criteria for the syndrome, such as elevated androgen levels or signs, like male-pattern hair growth (hirsutism), or irregular periods. 

For years, this massive disconnect created confusion for healthcare professionals and patients alike. Many women diagnosed with PCOS were told the name was something of a misnomer because it oversimplified what is actually a very complex, system-wide disorder.

The new name helps tell a much more complete story. Polyendocrine recognizes that multiple hormone systems are involved. Metabolic acknowledges the central role of insulin resistance and metabolic dysfunction. Ovarian syndrome ensures that menstrual cycle changes and ovarian findings remain an important part of the condition without suggesting they're the whole story.

But as is the case with any rebrand, the transition to PMOS won't happen overnight. Clinical guidelines, educational materials, and insurance coding systems will all need to be updated, so long story short, it’s going to be a minute until this takes place. Until then, you'll likely see both names used interchangeably, but the shift reflects something experts have known for a long time. The name is just finally catching up to match the science.

Why This Changes How We Think About the Condition

For years, conversations about PCOS were largely centered around fertility. Once a woman was finished having children, or never wanted them in the first place, the conversation often faded too. The PMOS framework recognizes that reproductive health is only one piece of a much bigger picture.

Insulin resistance, chronic inflammation, abnormal lipids, and an increased cardiovascular risk don't just disappear after your reproductive years. The truth is, these effects can span far into midlife and the years following and worsen over time without intervention. 

Conversations with your clinician may start focusing less on your menstrual cycle and more on your blood pressure, cholesterol level, blood sugars, liver health, body composition, and other metabolic markers.

How Perimenopause Amplifies PMOS Symptoms and Health Effects

Just when you think you've got PMOS management down, your hormones throw in another plot twist: perimenopause. This may mean that, despite sticking to your tried-and-true healthy, low-carb diet, you suddenly start noticing weight gain, especially around your midsection.

Or maybe your energy levels feel more depleted than usual. Or perhaps you don't even realize you've entered perimenopause because your periods have always been irregular, so how can you even go about identifying the difference? 

With so many overlapping symptoms, it can be difficult to tell what's coming from PMOS and what's coming from perimenopause. In many cases, it’s probably both. 

Estrogen helps support cardiometabolic health, including insulin sensitivity. So if PMOS is already contributing to insulin resistance and metabolic changes, declining estrogen can make those challenges even more noticeable.

Now, that doesn't mean every woman with PMOS will gain weight or develop type 2 diabetes. But it does help explain why midlife can feel like your symptoms have suddenly intensified, and why changes in your blood sugar, cholesterol, or other metabolic markers may become more apparent during this stage of life.

Symptoms That May Become More Noticeable

One of the most frustrating parts of having PMOS during perimenopause is that it can feel like the rules suddenly change as estrogen and progesterone decline and the balance between those hormones and your androgen levels ( testosterone and DHEA) begins to shift upwards.

Apart from weight gain, you may notice more frequent and intense brain fog, especially if blood sugar swings linked to PMOS and poor sleep linked to hormonal changes in perimenopause start exacerbating each other.

Getting a good night's sleep can feel like something of the past with hot flashes, night sweats, sleep apnea, and regular nighttime awakenings. Between disrupted sleep and underlying metabolic changes, it's not exactly surprising that you’d feel like you’d have to take a nap or two during the day.

While all of these symptoms may not seem connected, they aren't happening in isolation. They're often the result of multiple hormonal systems changing at the same time, which is exactly why PMOS can feel so much more difficult to manage during midlife.

“Night sweats can actually become quite intense from the perfect storm of hormonal lows, hypoglycemia due to insulin resistance, and hypoxia if there is sleep apnea, all of which can be culprits in a perimenopausal woman with PMOS.” - Dr Traci Kurtzer

The Conversation Is Begging to Enter the Workforce 

One of the more significant parts of the PMOS rebrand extends beyond the examination table. In its accompanying policy recommendations, the SWHR argues that conditions like PMOS shouldn't be viewed solely through a reproductive health lens. 

Instead, they're lifelong health conditions that can affect a woman's ability to work, care for family, and maintain her overall well-being. If you have PMOS you know better than anyone how symptoms like fatigue, brain fog, sleep disruption, and metabolic changes can affect your ability to do daily tasks.

The policy brief also encourages employers and healthcare systems to think more broadly about supporting women during midlife as they enter into perimenopause. This may include greater flexibility for medical appointments, workplace environments that better accommodate symptoms like heat intolerance, and improved access to tools that help women monitor their metabolic health when appropriate. 

Managing PMOS During Midlife

The PMOS rebrand isn't changing how the condition is treated overnight, but it is changing how many clinicians think about long-term treatment.

Lifestyle interventions remain foundational, but the focus may shift during midlife. Rather than trying to out-exercise changing hormones with more and more cardio, many experts recommend making strength training a bigger priority. Muscle plays a major role in glucose (sugar) metabolism, so building and maintaining lean muscle mass can help improve your insulin sensitivity while also supporting bone health and healthy aging.

Nutrition is also so important! For some women, medications that improve insulin sensitivity, such as metformin, continue to play a central role in treatment. Others may benefit from an inositol supplement or even GLP-1 Agonist medications.

A continuous glucose monitor (CGM) may also help provide some helpful data points for some people. Not everyone will need a CGM, but it can provide insight into how your body responds to different foods, exercise, stress, and even sleep, making it easier to identify patterns that might otherwise go unnoticed.

Anti-androgen therapy, i.e. spironolactone, can help prevent the excess hair where it’s not wanted (face and body) and loss of hair from androgenic alopecia, during this period. 

Hormone replacement therapy (HRT) may also help you navigate other hormonal symptoms during this life stage. While it isn't a treatment for PMOS itself, estrogen can help support metabolic health while addressing various menopause symptoms and low dose birth control pills or progestogens can be key in countering the estrogen dominance of PMOS and irregular, anovulatory cycles that can continue into early perimenopause.

Low-Dose Birth Control Pill

$39.99

1-month supply

Best for those in perimenopause (if you're still getting periods)

Start Now

Remember, PMOS and perimenopause often overlap, so the best treatment plan is one that keeps both conditions in mind.

Questions to Consider Asking Your Clinician

If you've lived with PCOS/PMOS for years, these new changes brought on my perimenopause may change how you’ve previously managed the condition, and that’s okay. Your care team is there to help, so don’t shy away from bringing a bunch of questions to your next appointment. 

Maybe you can ask:

"How does my history of PMOS affect my health during perimenopause and menopause?" 

This opens the conversation about how declining estrogen and underlying metabolic changes may interact during midlife.

"Can we look beyond my fasting glucose levels?" 

Ask whether additional testing, such as a fasting insulin level, HbA1c, or a more comprehensive lipid panel, would provide a better picture of your metabolic health.

"Am I a good candidate for menopause hormone therapy?" 

If you're experiencing menopause symptoms, ask how estrogen loss may affect your cardiometabolic health and whether hormone therapy is appropriate based on your individual medical history.

"Would a continuous glucose monitor be helpful?" 

While CGMs aren't necessary for everyone, they may help some women better understand how food, exercise, stress, and sleep affect their blood sugar during this transition.

You’re your number one advocate, so take charge of the conversation. You’ve got this!

Frequently Asked Questions

Why was PCOS officially renamed to PMOS?

The Endocrine Society and the Society for Women's Health Research updated the name to Polyendocrine Metabolic Ovarian Syndrome to accurately reflect a complex, lifelong endocrine and metabolic disorder. The original term was misleading because the condition is not actually caused by true ovarian cysts and extends far beyond reproductive health or fertility to impact systemic insulin resistance, cardiovascular health, and multi-organ hormone pathways.

How does perimenopause impact women living with PMOS?

Estrogen plays a critical role in supporting insulin sensitivity and metabolic function. As estrogen levels drop during perimenopause, existing PMOS-related metabolic challenges often intensify, leading to sudden abdominal weight gain, pronounced brain fog, severe sleep disruptions like night sweats or sleep apnea, and increased shifts in blood pressure, cholesterol, and blood sugar levels.

What are the most effective strategies for managing PMOS in midlife?

Midlife management shifts away from high-intensity cardio toward strength training, which builds lean muscle mass to improve glucose metabolism. Treatment plans frequently incorporate insulin-sensitizing options like metformin, GLP-1 agonists, or inositol, alongside anti-androgen therapy for hair changes, continuous glucose monitoring (CGM) for real-time blood sugar tracking, and hormone replacement therapy (HRT) to counteract estrogen decline.